Inactive Instrument
2cureX AB Share Price
Stocks
2CUREX
SE0010468124
Biotechnology & Medical Research
|
Delayed
Nasdaq Stockholm
17:00:00 31/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.4200 SEK | -12.13% |
|
-16.00% | -18.29% |
| 08-25 | 2Curex begins the process for a listing on Spotlight | FW |
| 08-18 | 2cureX Flags Delisting from Nasdaq First North Growth Market | MT |
Last Transcript: 2cureX AB
| 1 day | -12.13% | ||
| 1 week | -16.00% | ||
| 1 month | -75.32% | ||
| 3 months | -76.92% | ||
| 6 months | -72.00% | ||
| Current year | -18.29% |
| 1 week | 0.41 |  | 0.53 |
| 1 month | 0.4 | | 1.72 |
| Current year | 0.4 | | 3.27 |
| 1 year | 0.4 | | 3.27 |
| 3 years | 0.2 | | 5.52 |
| 5 years | 0.2 | | 19.4 |
| 10 years | 0.2 | | 31.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Grith Hagel
COO | Chief Operating Officer | 67 | 31/12/2005 |
Ole Thastrup
CEO | Chief Executive Officer | 73 | - |
| Chief Executive Officer | 50 | 28/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Ole Thastrup
CHM | Chairman | 73 | 15/12/2024 |
Grith Hagel
BRD | Director/Board Member | 67 | 31/12/2005 |
| Chairman | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.13% | -16.00% | - | - | 1.4M | |
| +1.85% | +7.32% | +421.33% | +147.75% | 4.98B | |
| -0.47% | +2.87% | +122.62% | +429.32% | 4.7B | |
| -6.41% | +14.16% | +35.86% | +101.20% | 3.65B | |
| +3.76% | +18.30% | +326.52% | +765.22% | 3.29B | |
| +2.50% | +13.65% | -7.45% | -14.14% | 2.58B | |
| -4.59% | -8.24% | +48.11% | - | 1.72B | |
| -0.58% | +0.59% | +36.00% | +63.46% | 1.14B | |
| -0.65% | +9.04% | +169.50% | -16.85% | 1.13B | |
| +5.08% | +8.18% | -21.14% | +142.84% | 629M | |
| Average | -1.16% | +7.40% | +125.71% | +202.35% | 2.65B | |
| Weighted average by Cap. | -0.15% | +8.59% | +174.81% | +260.08% |
Employees
14
Calendar
- Stock Market
- Stocks
- 2CUREX Stock
Select your edition
All financial news and data tailored to specific country editions
